Manufacturer record
CIPCO Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by CIPCO Limited (Madhya Pradesh) were declared Not of Standard Quality between January 2026 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AT25J325, Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup (exp Jun 2027). DTL Jaipur (state lab) found it not of standard quality: The sample does not conform to the claim with respect to in Assay of Ambroxol Hydrochloride. Listed in the February 2026 alert.
Records by type
8 records linked to CIPCO Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT25J325Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to the claim with respect to in Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Feb 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT23J325Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to the claim with respect to in Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Feb 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT31J325Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Feb 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT18S125Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to the claim with respect to In Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Jan 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT22A225Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Jan 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT13A225Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Jan 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT48J325Mfg Jul 2025 · Exp Jun 2027 | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Jan 2026 |
| Ambroxol Hydrochloride, Terbutaline Sulphate and Guaiphenesin Syrup | Batch AT11S125Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to the claim with respect to Assay of Ambroxol Hydrochloride.Assay | DTL JaipurState lab | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.